{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:52:35Z","timestamp":1793994755113,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ahj.2026.107440","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:42:52Z","timestamp":1775180572000},"page":"107440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rationale and design of the Corrie Lipids Program: Impact of a digital health\u2013enabled implementation initiative to improve lipid management"],"prefix":"10.1016","volume":"298","author":[{"given":"Allison W.","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline F.","family":"Plott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Asghar","family":"Kassamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laney K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemme","family":"Campbell-Salome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"Kalich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared A.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farbaniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise A.","family":"Marvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107440_bib0001","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990\u20132021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0002","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2025.05.018","article-title":"JACC data report: cardiovascular disease mortality trends in the United States (1999\u20132023)","volume":"85","author":"Yan","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0003","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amepre.2023.11.009","article-title":"Trends in cardiovascular disease mortality rates and excess deaths, 2010\u20132022","volume":"66","author":"Woodruff","year":"2024","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0004","first-page":"e41","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(02)08351-4","article-title":"Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107440_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107440_bib0007","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0008","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0009","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","article-title":"Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0011","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0012","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0013","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0014","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107440_bib0016","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib49","article-title":"ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0017","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.02.048","article-title":"High-intensity statin use among patients with atherosclerosis in the U.S","volume":"79","author":"Nelson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100959","article-title":"Disparities in statin use in patients with ASCVD with vs without rheumatologic diseases in a large integrated healthcare system: Houston methodist CVD learning health system registry","volume":"22","author":"Avenatti","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0019","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.amjcard.2019.04.017","article-title":"Adherence to blood cholesterol treatment guidelines among physicians managing patients with atherosclerotic cardiovascular disease","volume":"124","author":"Ramsaran","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0020","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/eurjpc\/zwae233","article-title":"Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in Wales","volume":"31","author":"Harris","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009251","article-title":"Measurement of low-density lipoprotein cholesterol levels in primary and secondary prevention patients: insights from the PALM Registry","volume":"7","author":"Lowenstern","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107440_bib0022","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/CLEP.S259757","article-title":"Lipid testing trends in the US before and after the release of the 2013 cholesterol treatment guidelines","volume":"12","author":"Levintow","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.9211","article-title":"Qualitative exploration of barriers to statin adherence and lipid control: a secondary analysis of a randomized clinical trial","volume":"4","author":"Barankay","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2026.107440_bib0024","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinternmed.2009.525","article-title":"Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey","volume":"170","author":"Persell","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000154568.43333.82","article-title":"National study of physician awareness and adherence to cardiovascular disease prevention guidelines","volume":"111","author":"Mosca","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2012.10.005","article-title":"Modifiable factors associated with failure to attain LDL cholesterol goal at 6-months after acute myocardial infarction","volume":"165","author":"Martin","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107440_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ahj.2024.06.012","article-title":"Achievement of LDL-C <55 mg\/dL among US adults: findings from the cvMOBIUS2 registry","volume":"279","author":"Navar","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107440_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007741","article-title":"Digital health intervention in acute myocardial infarction","volume":"14","author":"Marvel","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2026.107440_bib0029","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/MLR.0000000000001636","article-title":"Cost-effectiveness of a digital health intervention for acute myocardial infarction recovery","volume":"59","author":"Bhardwaj","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2026.107440_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41440-024-01939-6","article-title":"Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis","volume":"48","author":"Abe","year":"2025","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ahj.2026.107440_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033328","article-title":"Comprehensive cardiovascular risk factor control with a mobile health cardiovascular risk self-management program","volume":"13","author":"Paz","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107440_bib0032","doi-asserted-by":"crossref","DOI":"10.2196\/41076","article-title":"Mobile health apps for the control and self-management of type 2 diabetes mellitus: qualitative study on users\u2019 acceptability and acceptance","volume":"8","author":"Bults","year":"2023","journal-title":"JMIR Diabetes"},{"key":"10.1016\/j.ahj.2026.107440_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.33629","article-title":"Mobile health intervention in patients with type 2 diabetes: a randomized clinical trial","volume":"6","author":"Gerber","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2026.107440_bib0034","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ahj.2026.107440_bib0035","unstructured":"American Heart Association. 2018 prevention guidelines tool CV risk calculator. https:\/\/static.heart.org\/riskcalc\/app\/index.html#!\/baseline-risk. Accessed October 2, 2025."},{"key":"10.1016\/j.ahj.2026.107440_bib0036","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ahj.2026.107440_bib0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","article-title":"RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review","volume":"7","author":"Glasgow","year":"2019","journal-title":"Front Public Health"},{"key":"10.1016\/j.ahj.2026.107440_bib0038","series-title":"Qualitative Psychology: A Practical Guide to Research Methods","first-page":"53","article-title":"Grounded theory","author":"Charmaz","year":"2024"},{"key":"10.1016\/j.ahj.2026.107440_bib0039","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/jcm12093187","article-title":"Real-world attainment of low-density lipoprotein cholesterol goals in patients at high risk of cardiovascular disease treated with high-intensity statins: the TERESA study","volume":"12","author":"Barrios","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ahj.2026.107440_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.838466","article-title":"Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals","volume":"120","author":"Waters","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107440_bib0041","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jacc.2024.03.388","article-title":"A technology-assisted web application for consumer access to a nonprescription statin medication","volume":"83","author":"Nissen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13012-021-01108-0","article-title":"Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis","volume":"16","author":"Jones","year":"2021","journal-title":"Implement Sci"},{"key":"10.1016\/j.ahj.2026.107440_bib0043","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.23935","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease","volume":"46","author":"Desai","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2026.107440_bib0044","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020893","article-title":"What do US physicians and patients think about lipid-lowering therapy and goals of treatment? Results from the GOULD registry","volume":"10","author":"Arnold","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107440_bib0045","first-page":"214","article-title":"Patient-centered education in dyslipidemia management: a systematic review","volume":"16","author":"Ismail","year":"2023","journal-title":"Asian Biomed (Res Rev News)"},{"key":"10.1016\/j.ahj.2026.107440_bib0046","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cvdhj.2021.05.003","article-title":"Heart rate trajectories in patients recovering from acute myocardial infarction: a longitudinal analysis of Apple Watch heart rate recordings","volume":"2","author":"Weng","year":"2021","journal-title":"Cardiovasc Digit Health J"},{"key":"10.1016\/j.ahj.2026.107440_bib0047","article-title":"Early blood pressure assessment after acute myocardial infarction: insights using digital health technology","volume":"3","author":"Shan","year":"2020","journal-title":"Am J Prev Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:45:59Z","timestamp":1778935559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032600102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S000287032600102X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107440","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Corrie Lipids Program: Impact of a digital health\u2013enabled implementation initiative to improve lipid management","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107440"}}